CDC20 and melanoma: Although our analysis identified other promising candidates, including the presence of several ribosomal genes, one of which has been previously validated9, we chose to focus on characterizing variants in the promoter of CDC20, whose weighted rate of recurrence and predicted functional significance were greater than that of the well-studied TERT promoter variants and began to investigate how these variants alter melanoma behavior.